History | Faricimab for treating wet age-related macular degeneration | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 142 KB)

Published:

29 June 2022
Register of interests (PDF 272 KB)

Published:

29 June 2022

Final draft guidance

Final draft guidance
Final appraisal document (PDF 155 KB)

Published:

24 May 2022
Committee papers (PDF 2.12 MB)

Published:

24 May 2022

Invitation to participate

Final scope (PDF 191 KB)

Published:

21 September 2021
Final stakeholder list (PDF 196 KB)

Published:

01 October 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 320 KB)

Published:

01 October 2021
Equality impact assessment (Scoping) (PDF 122 KB)

Published:

01 October 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 206 KB)

Published:

20 April 2021
Draft matrix post referral (PDF 193 KB)

Published:

20 April 2021